We are proud to share the featured speakers for the 2023 Baylor College of Medicine Alumni Reunion.
Pavan Reddy, M.D., is the Director of the Dan L Duncan Comprehensive Cancer at Baylor College of Medicine. In addition to this role, he is Senior Associate Dean of Cancer Programs and holds an executive physician leadership role/leading all Oncology Services, research, and strategic growth at Baylor St. Luke’s Medical Center / O’Quinn.
As a physician-scientist, Dr. Reddy does both bench and translational research, his work is focused on understanding the role of immune cells in blood diseases, cancer and transplantation. His groundbreaking research is supported by funding from the National Institutes of Health, the Leukemia and Lymphoma Society, and other foundations.
Dr. Reddy was born and raised in India. He earned his medical degree from Osmania University in Hyderabad in 1994 then came to the United States where he completed a residency in internal medicine at the University of Missouri in 1998. Following the completion of fellowships in hematology/oncology and bone and marrow transplantation at the University of Michigan, he joined the U-M faculty in 2002 and began to co-direct the Bone Marrow Transplant Program and the Hematologic Malignancies Program since 2011. He served as the Chief of the Division of Hematology/Oncology and Deputy Director of the Rogel Cancer Center at University of Michigan until September 2022, when he joined Baylor College of Medicine as the Director of the Dan L Duncan Comprehensive Cancer Center in Houston, Texas. He is the author or co-author of over 250 peer-reviewed journal articles and book chapters. Dr. Reddy has received many honors, including the Jerome Conn Award from department of medicine, awards from national societies including the election to honorary societies such as American Society of Clinical Investigation (ASCI), Association of American Physicians (AAP), and American Clinical and Climatological Association (ACCA). He holds leadership roles in multiple scientific committees and served as the immediate past-President of the American Society of Transplantation and Cellular Therapy (ASTCT), scientific committees of the American Society of Hematology (ASH), NIH panels. He is the Deputy Editor of JCI Insight, and Associate Editor for the journals Hematologica, Transplantation and Cellular Therapy.
In the laboratory, Dr. Reddy focuses on the immunobiology of graft-versus-host disease (GVHD), a devastating immune response that can occur after a stem cell or bone marrow transplant in which the newly transplanted donor cells attack the transplant recipient’s body. Dr. Reddy hopes to translate the knowledge he gains through his research into powerful, lifesaving treatments for patients everywhere. His research has been continuously funded by the NIH with multiple grants for over 20 years.
Dr. Reddy and his wife Dr. Madhulata Reddy have two sons: Sidharth and Saahith.
